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Gobind Khorana was a scientist who
traversed boundaries, both scientifically
and culturally. He pioneered the use of
concepts and tools from chemistry and
physics to tackle fundamental questions
of biology. In particular, he helped to
decipher how RNA encodes for the
synthesis of protein, research that earned
him the Nobel Prize in Medicine with
Marshall Nirenberg and Robert Holley in
1968. Although deeply modest and unas-
suming, Gobind would often remark, ‘‘I
only work on big problems.’’ Indeed,
only such challenges were worthy of the
extraordinary intensity, creativity, and
focus that Gobind brought to a question.
Gobind is an international icon for
science sans frontiers. He was an early
practitioner of what is now known as
Chemical Biology. He pioneered new
synthetic routes for nucleotide cofactors
and oligonucleotides and then used these
synthetic molecules to help elucidate theHar Gobind Khoranagenetic code. He assembled the first
synthetic gene, thereby developing
what might be described as the first
‘‘biobrick’’ and laying the founda-
tion for Synthetic Genomes and
Synthetic Biology. In 1971, shortly
after his departure from University of
Wisconsin-Madison (UW-Madison)
to the Massachusetts Institute of
Technology (MIT), he described the
amplification of synthetic genes in
a series of steps that were redefined
15 years later, with a thermostable
DNA polymerase, as PCR. At MIT,
Gobind took on lipids andmembrane
proteins, focusing on the structure
and function of bacteriorhodopsin
and then mammalian rhodopsin until
his retirement in 2007.
The intellectual elegance of
Gobind’s work has been an inspira-
tion for many generations of chem-
ists and biologists, but the high visi-
bility of his success has had a much
broader and deeper impact on India,
especially while it was struggling to
gain its footing after India’s indepen-
dence from the United Kingdom. In
India, Gobind is a symbolic figurefor how an education can help to over-
come socioeconomic and intellectual
boundaries. His success was hard won
and quite improbable.
Gobind began his education under
a tree in a small village of a hundred
families, who were mostly illiterate. Fortu-
nately, his talent was recognized early,
and he went on to Punjab University in
Lahore and almost became an English
major because he was too shy to inter-
view for the Chemistry program. Never-
theless, the selection committee over-
looked this because of his talent, and he
graduated with a Masters in Chemistry.
He then won a rare fellowship to pursue
a Ph.D. in organic chemistry at the Univer-
sity of Liverpool in England.
After obtaining his doctorate in 1948,
Gobind enthusiastically moved to Eidge-
no¨ssische Technische Hochschule (ETH)
in Zurich to join the group of Vladimir
Prelog, a chemist who won a Nobel PrizeCell 147, Dein 1975 for his work on stereochemistry. In
less than a year, he had to leave Zurich
because his savings ran out. During his
brief tenure at the ETH, however, Gobind
serendipitously encountered the little-
known work of Fritz Zetzsche on carbo-
diimides. This class of compounds
became incredibly important for Gobind
to synthesize nucleotide cofactors (such
as coenzyme A) and ATP with ‘‘aston-
ishing rapidity,’’ as he would later state
in his reflections.
Gobind was unable to find a position
in India after training at ETH, a setback
that became a blessing in disguise. He
instead received a three-year fellowship
with Alexander Todd at Cambridge
University. While at Cambridge, Gobind
was exposed to Sanger’s exciting ad-
vances in protein sequencing, Perutz’s
and Kendrew’s breakthroughs in protein
crystallography, and Todd’s own work
on the chemical structures of nucleic
acids. This innovative environment drew
Gobind, a synthetic organic chemist, to
the newborn field of Molecular Biology.
In 1952, Gobind began his indepen-
dent scientific career as a nonacademic
researcher at the British ColumbiacembResearch Council in Vancouver,
Canada. His meteoric rise and sus-
tained string of seminal scientific
contributions might be grouped
roughly into two phases. The first
phase focused on nucleotides and
nucleic acids. He used a carbodii-
mide (i.e., dicyclohexylcarbodiimide)
to formpyrophosphate bonds, which
eventually led to the first synthesis of
coenzyme A and ATP. Soon, Gobind
wrote to Van Potter, a leading cancer
biologist atUW-Madison, asking if he
would test his synthetic ATP in
rigorous biochemical assays. Van
Potter not only obliged with the
experiments, but also succeeded in
bringing Gobind to the Institute for
Enzyme Research, a vanguard of
chemical biology at UW-Madison.
From 1960 to 1970, Gobind
was co-Director of the ‘‘Enzyme
Institute’’ and a member of the
Department of Biochemistry at UW-
Madison. During this period, he gen-
erated synthetic oligonucleotides
and amplified these molecules bio-
synthetically with DNA polymerase,
which he learned to purify in Arthurer 23, 2011 ª2011 Elsevier Inc. 1433
Gobind with two Khorana scholarsKornberg’s lab. Using the oligonucleotide
CUCUCU, he discovered that the triplets
CUC and UCU encode the amino acids
leucine and a serine, respectively. This
work corroborated the studies of Marshall
Nirenberg, who had previously shown
that aUUU triplet encoded a phenylalanine
residue. Gobind, with his characteristic
humility, would always note that Niren-
berg’swork inspiredhis own investigations
of the genetic code.
By this time,Gobindwas already setting
his sights on synthesizing a complete
gene, even though the understanding of
a gene was still far from concrete. Using
DNA ligases, Gobind’s lab assembled
the coding region of the gene for the
alanine tRNA.By 1976,Gobind had added
the required regulatory elements needed
to express the gene in a living bacterial
cell and demonstrated that the synthetic
tRNA functioned identically to the natu-
rally expressed gene. This tour de force
work defined the conceptual and tech-
nical framework for biotechnology and,
40 years later, is still the strategy used to
assemble synthetic genes and genomes.
The second phase of Gobind’s career
began at MIT. He focused on two general
areas: to identify the mechanism by which
intrinsic membrane proteins function and
to map their interactions on a molecular
scalewith phospholipids of the lipid bilayer
structure. Gobind became particularly1434 Cell 147, December 23, 2011 ª2011 Elsintrigued by light-sensitive bacteria, with
a specific interest in the purple mem-
branes of Halobacterium halobium. This
project led to the characterization of
H. halobium bacteriorhodopsin and, even-
tually, mammalian rhodopsin—the last
great problem tackled by the Khorana lab.
The strategy that he chose for this
project was a forerunner of contemporary
systems biology: sequence the protein,
mutate every residue, express and recon-
stitute the proteins in a native biological
context, and then meticulously monitor
the phenotypic perturbations, with the
eventual goal to provide a comprehensive
solution to the problem of bioenergetics.
In the process, he corrected misimpres-
sions related to the mechanism of
rhodopsin, including the location of the
retinal chromophore in bacteriorhodopsin
and the transmembrane structure of
bacteriorhodopsin. Through the efforts
of countless colleagues and collabora-
tors, Gobind elucidated the detailed
mechanism by which bacteriorhodopsin
pumps protons across the membrane
when activated by light. Similar ap-
proaches were then used to determine
the mechanism and structure-function
relationships in mammalian rhodopsin,
a problem that engaged Gobind until his
death. Characteristically, Gobind tackled
this question with the fervor and energy
of a newly minted assistant professor.evier Inc.Inspired by Gobind’s story, UW-
Madison launched the Khorana Scholars
Program in 2007, the year Gobind retired
from active research. Gobind generously
lent his name to the program, which
aims to identify and nurture future
leaders in both the United States and
India. This exchange program identifies
talented American and Indian students
and places them in leading laboratories
for a transformative summer research
experience in the host country. The Khor-
ana program is now expanding to partner
with top US universities and leading
Indian scientific institutes. The program
also sends Wisconsin agricultural scien-
tists to India to assist in entrepreneurial
efforts aimed at improving economic
stability and food security in poor rural
areas (http://www.biochem.wisc.edu/
faculty/ansari/khorana_program). During
his last visit to UW-Madison, Gobind met
the 2009 scholars. His joy at meeting the
future generation of scientists stemmed
from seeing their passion for science
and perhaps recognizing a bit of himself
in them.
Gobind’s passion for science and the
exacting standards that he set enabled
many of his students to become leaders
in industry and academia. His postdoc-
toral fellow Michael Smith won the Nobel
Prize in 1993 for site-directed mutagen-
esis, ironically sharing the award with
Kary Mullis, who was honored for invent-
ing PCR. Other trainees founded major
biotech companies, such as Amgen, and
became presidents of leading educational
institutions and research centers.
Gobind’s mentorship involved rigorous
intellectual training and hard work. It did
not matter if none of the experiments
worked (at least for the impossible prob-
lems!), but complete ‘‘24/7’’ engagement
was expected. One possibly apocryphal
story involved Saturday morning donuts
that Gobind would bring to the lab. Rumor
had it that he had identified everyone’s
favorite type of donut and would bring
only one each. At the end of the day, he
would check the remaining donuts and
determine who had come in over the
weekend!
Although the lab worked hard, it also
sharedmanymemorable Friday night ses-
sions in a room above the Muddy Charles
pub at MIT—meetings where spouses,
children, and dogs were all welcome.
Gobind’s lab drew from many disciplines
and countries, and thus it populated
faculty positions across the world. He
treated women exactly the same as men
(‘‘Want to race up the stairs?’’ he often
asked M.R.R.); a former postdoctoral
fellow even became one of Japan’s first
female biochemistry professors.
The respect and warmth felt by
Gobind’s academic family was readily
evident in the periodic ‘‘Khorana
Symposia,’’ which were held in various
parts of the world. The last such gathering
was in 2009 at the 33rd Steenbock
symposium on Synthetic Gene to
Synthetic Genomes. Many of the scien-
tists that spoke, in describing their current
work, noted how Gobind shaped their
thinking and how his contributions
continue to propel new fields, such as
synthetic and chemical biology. Asa tribute to Gobind, UW-Madison has
made these talks publicly accessible at
http://www.biochem.wisc.edu/seminars/
steenbock/symposium33.
Gobind had a deep interest in nature
and its beauty; he actively sought solitude
in natural settings to think deeply and crit-
ically about science. His beloved wife
Esther, whom he lost in 2001, ensured
that he was free to focus exclusively on
science. He would often rent a room or
cottage without a phone, radio, or TV so
that he could think and write without
distraction. In fact, Esther had to drive
an hour to inform Gobind that he had
won the Nobel Prize. Gobind tragically
lost his daughter Emily in 1978 but is
survived by his loving children David and
Julia, who cared for him in his final years.
Har Gobind Khorana was an influential
scientist, a rigorous educator, and aCell 147, Dehumanitarian. He pursued his work with
a single-minded intensity but remained
humble to the end. His innate curiosity
and appreciation of life (as well as that
quick laugh, that slight tilt as he craned
his head to listen, and that quizzical
look) will remain with those who were
fortunate to be his friend. His legacy will
live on through generations. If one wants
an appreciation of the great scientific
oeuvre of Gobind Khorana, the best place
to look is a book of selected papers
complete with introductions compiled by
Gobind a few years ago (Khorana, H.G.
[2000]. Chemical Biology: Selected
Papers of H. Gobind Khorana [with Intro-
ductions] [Singapore: World Scientific
Publishing Co. Pte. Ltd.]).
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